loadpatents
name:-0.010555028915405
name:-0.0062730312347412
name:-0.0015580654144287
Sausville; Edward A. Patent Filings

Sausville; Edward A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sausville; Edward A..The latest application filed is for "aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia".

Company Profile
1.7.10
  • Sausville; Edward A. - Edgewater MD US
  • Sausville; Edward A. - Silver Spring MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment agents for inhibiting HIV and cancer in HIV infected patients
Grant 11,364,242 - Redfield , et al. June 21, 2
2022-06-21
Aziridinyl And Amino Dimeric Naphthoquinone Compounds And Use For Acute Myeloid Leukemia
App 20200283417 - Emadi; Ashkan ;   et al.
2020-09-10
Treatment Agents for Inhibiting HIV and Cancer in HIV Infected Patients
App 20200016160 - Redfield; Robert R. ;   et al.
2020-01-16
Treatment Agents For Inhibiting Hiv And Cancer In Hiv Infected Patients
App 20160339030 - Redfield; Robert R. ;   et al.
2016-11-24
Use of plasma HSP90 related to malignancy
Grant 8,580,519 - Burger , et al. November 12, 2
2013-11-12
Arnt Isoform 3 As A Predictor Of Aminoflavone Responsiveness In Cancer Cells
App 20130177904 - Gnatt; Averell L. ;   et al.
2013-07-11
Use Of Plasma Hsp90 Related To Malignancy
App 20100129829 - Sausville; Edward A. ;   et al.
2010-05-27
Disubstituted lavendustin A analogs and pharmaceutical composition comprising the analogs
Grant 6,943,191 - Narayanan , et al. September 13, 2
2005-09-13
Geldanamycin derivative and method of treating cancer using same
Grant 6,890,917 - Snader , et al. May 10, 2
2005-05-10
Geldanamycin derivative and method of treating cancer using same
App 20040053909 - Snader, Kenneth M. ;   et al.
2004-03-18
Fused azepinone cyclin dependent kinase inhibitors
Grant 6,610,684 - Zaharevitz , et al. August 26, 2
2003-08-26
Fused azepinone cyclin dependent kinase inhibitors
App 20020042412 - Zaharevitz, Daniel W. ;   et al.
2002-04-11
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed